Company Overview and News
The New York Times published an interesting article May 21 that looked at the Marx ratio, which is defined as a company’s profit per employee divided by the median wage of its employees; it tells us generally how much a public company rewards its shareholders in comparison to its employees. Numbers below 1 mean the company is returning more to employees than shareholders, while numbers above 1 means the opposite.
The greenback has been on an ascent, with PowerShares DB US Dollar Index Bullish Fund (UUP - Free Report) returning about 3.1% in the last one month (as of May 22, 2018). Steady U.S. economic recovery, which has proved sturdier than other developed economies in recent times and a prospects of faster-than-expected Fed rate hikes this year boosted the greenback.
PRELIMINARY PRICING SUPPLEMENT No. 51 Filed Pursuant to Rule 424(b)(2) Registration No. 333-221324 The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying market measure supplement, prospectus supplement and prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdi
NEW YORK (AP) — Five months after massive federal tax changes became law, many small business owners still don't know whether they'll be winners or losers.
Small and regional banks are the big beneficiaries of the House-approved bank regulatory relief bill making its way to President Trump's desk for signature this week
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
The long-time demand of banks to scale back stringent regulations is finally a reality. The House passed a crucial bill easing some provisions of the 2010 Dodd-Frank Act that were put in place as safeguard against repeat of the 2008 financial crisis. The House passed the bill on Tuesday backed by majority voting of 258 to 159, promising it to be beneficial for small and mid-sized banks. It would now be presented to President Donald Trump for signing, with the Senate already having passed the legislation in March.
Cosmo Pharmaceuticals announced that the FDA has set a PDUFA date of November 16, 2018, to decide on its NDA for Rifamycin.
Good afternoon. My name is Latif and I will be your conference facilitator. At this time, I would like to welcome everyone to Intuit’s Third Quarter Fiscal Year 2018 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session period. [Operator Instructions]
Urban Outfitters, Inc. (NASDAQ:URBN) Q1 2019 Results Earnings Conference Call May 22, 2018 5:00 PM ET
Good morning, my name is Regina and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Wabtec and GE Transportation merger conference call. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question and answer session. [Operator Instructions]
The hunt for yield never ends. Even though interest rates are rising, investors are hunting for different types of securities that throw off income. The good news is that there are high-yielding securities out there, and you don’t have to get too aggressive to find them.
IHS Markit Ltd (NASDAQ:INFO) Acquisition of Ipreo and Intent to Divest MarkitSERV Conference May 21, 2017 8:00 AM ET
Good day ladies and gentlemen, and welcome to Nordson Corporation Webcast for Second Quarter Fiscal Year 2018. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions for how to participate will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
Advance Auto Parts, Inc. (NYSE:AAP) Q1 2018 Earnings Conference Call May 22, 2018 8:00 AM ET
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET